
Ácidos Graxos e Derivados Lipídicos
Os ácidos graxos são moléculas formadas por uma longa cadeia de hidrocarbonetos com um grupo carboxila (-COOH) em uma extremidade. Essas estruturas conferem-lhes uma grande capacidade de interagir com as membranas celulares e desempenham papéis fundamentais no metabolismo energético, no armazenamento de gorduras e na regulação hormonal. Os derivados dos ácidos graxos são utilizados em cosméticos, produtos farmacêuticos e como componentes na produção de biocombustíveis.
Na CymitQuimica, oferecemos ácidos graxos e seus derivados para aplicações em química orgânica, bioquímica e desenvolvimento farmacêutico.
Foram encontrados 32215 produtos de "Ácidos Graxos e Derivados Lipídicos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
(3-Methyl-2-oxo-2,3-dihydro-imidazo[1,2- a ]pyridin-3-yl)-acetic acid
CAS:Pureza:95.0%Cor e Forma:SolidPeso molecular:206.20100402832035-(2-furyl)-2H-1,2,6-thiadiazine-3-carboxylic acid 1,1-dioxide
CAS:Fórmula:C8H6N2O5SPeso molecular:242.21Vildagliptin Amide
CAS:Produto Controlado<p>Impurity Vildagliptin Amide Impurity<br>Applications N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-prolinamide is an impurity of Vildagliptin (V305000) which is an oral anti-hyperglycemic agent that inhibit dipeptidyl peptidase 4 (DPP-4).<br>References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),<br></p>Fórmula:C17H27N3O3Cor e Forma:Off-WhitePeso molecular:321.412-Nonenedioic Acid
CAS:Produto Controlado<p>Applications 2-Nonenedioic Acid is an impurity of Azelaic acid (A808140) which is an antiacne agent.<br>References Bladon, P.T., et al.: Br. J. Dermatol., 114, 493 (1986)<br></p>Fórmula:C9H14O4Cor e Forma:White To Light BeigePeso molecular:186.21Niflumic Acid-d5 (Major)
CAS:Produto Controlado<p>Applications Anti-inflammatory. Selective cyclooxygenase-2 (COX-2) inhibitor.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Glasson, et al.: Biochem, Pharmacol., 18, 633 (1969), Boissier, et al.: Therapie, 26, 211 (1971), Sorenson, J.R.J., et al.: J. Med. Chem., 19, 135 (1976), Barnett, J., et al.: Biochim. Biophys. Acta, 1209, 130 (1994), Johnson, J.L., et al.: Arch. Biochem. Biophys., 324, 26 (1995),<br></p>Fórmula:C13H4D5F3N2O2Cor e Forma:NeatPeso molecular:287.25(2S)-1-(2-Chloroacetyl)-2-9-pyrrolidinecarbonitrile
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications (2S)-1-(2-Chloroacetyl)-2-9-pyrrolidinecarbonitrile is a key intermediate for dipeptidyl peptidase IV inhibitor Vildagliptin (V305000).<br>References Singh, S.K., et al.: Beil. J. Org. Chem., 4, 20 (2008);<br></p>Fórmula:C7H9ClN2OCor e Forma:NeatPeso molecular:172.61Ezetimibe Diol Impurity
CAS:Produto ControladoFórmula:C24H25F2NO3Cor e Forma:NeatPeso molecular:413.46Nonafluoro-1-butanesulfonic Acid
CAS:<p>Stability Moisture Sensitive<br>Applications Perfluorobutanesulfonic acid (PFBS) is a stable fluorosurfactant because of the strength of carbon–fluorine bonds. PFBS has served as a replacement for the persistent, toxic, and bioaccumulative perfluorooctanesulfonic acid (PFOS) in 3M's Scotchgard stain repellents. PFBS is neither toxic nor bioaccumulative.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Renner R., et al.: Environ. Sci. Technol., 40, 12 (2006), Betts, K.S., et al.: Environ. Health Perspect., 115, 250 (2007),<br></p>Fórmula:C4HF9O3SCor e Forma:Colourless LiquidPeso molecular:300.108-ethyl-4-(thiophene-2-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Pureza:95.0%Peso molecular:324.3999938964844Vildagliptin Racemic
CAS:<p>Applications Vildagliptin Racemic is an impurity of Vildagliptin (V305000),a class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.<br>References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),<br></p>Fórmula:C17H25N3O2Cor e Forma:NeatPeso molecular:303.3994’-O-Benzyloxy Ezetimibe
CAS:Produto Controlado<p>Impurity Ezetimibe Benzyl Ether Impurity<br>Applications Protected Ezetimibe, used for the synthesis of related derivatives.<br>References Raman, B., et al.: J. Pharm. Biomed. Anal., 52, 73 (2010),<br></p>Fórmula:C31H27F2NO3Cor e Forma:NeatPeso molecular:499.556-[(1E)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-5,6-dihydro-4-hydroxy-2H-pyran-2-one
CAS:<p>Impurity Fluvastatin EP Impurity E<br>Applications 6-[(1E)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-5,6-dihydro-4-hydroxy-2H-pyran-2-one (Fluvastatin EP Impurity E) is an impurity of Fluvastatin (F601250), a synthetic HMG-CoA reductase inhibitor. Antilipemic.<br>References Yuan, J., et al.: Atherosclerosis, 87, 147 (1991), Tse, F.L.S., et al.: J. Clin. Pharmacol., 32, 630 (1992), Dain, J.G., et al.: Drug Metab. Disposit., 21, 567 (1993)<br></p>Fórmula:C24H22FNO3Cor e Forma:NeatPeso molecular:391.43

